Radiometallated peptides for molecular imaging and targeted therapy. (Q37847064)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Radiometallated peptides for molecular imaging and targeted therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

António Paulo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

Paula D. Raposinho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

Isabel Santos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

author name string

João D G Correia

1

1 reference

24 August 2017

António Paulo

2

1 reference

24 August 2017

Paula D Raposinho

3

1 reference

24 August 2017

Isabel Santos

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

25 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

6144-6167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

Peptide receptors as molecular targets for cancer diagnosis and therapy

23 January 2020

cites work

1 reference

Nuclear imaging probes: from bench to bedside

21 January 2018

1 reference

Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies.

21 January 2018

1 reference

Molecular imaging targeting peptide receptors

21 January 2018

1 reference

Peptide-targeted diagnostics and radiotherapeutics

21 January 2018

1 reference

Peptide-based probes for cancer imaging

21 January 2018

1 reference

Antibody vectors for imaging

21 January 2018

1 reference

Preclinical and clinical studies of peptide receptor radionuclide therapy

21 January 2018

1 reference

Peptide receptor therapies in neuroendocrine tumors.

21 January 2018

1 reference

Peptide-receptor radionuclide therapy for endocrine tumors

21 January 2018

1 reference

Tumor imaging and therapy using radiolabeled somatostatin analogues.

21 January 2018

1 reference

Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

Peptides and peptide hormones for molecular imaging and disease diagnosis

21 January 2018

1 reference

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

21 January 2018

1 reference

Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals

21 January 2018

1 reference

Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).

21 January 2018

1 reference

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease

21 January 2018

1 reference

Synthesis of target-specific radiolabeled peptides for diagnostic imaging

21 January 2018

1 reference

The synthesis and chelation chemistry of DOTA-peptide conjugates

21 January 2018

1 reference

Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data

21 January 2018

1 reference

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

21 January 2018

1 reference

Synthesis and structural characterization of complexes of a DO3A-conjugated triphenylphosphonium cation with diagnostically important metal ions

21 January 2018

1 reference

NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors

21 January 2018

1 reference

Neuroendocrine tumors. Peptide receptor radionuclide therapy

21 January 2018

1 reference

Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy

21 January 2018

1 reference

Comparison of yttrium and indium complexes of DOTA-BA and DOTA-MBA: models for (90)Y- and (111)In-labeled DOTA-biomolecule conjugates

21 January 2018

1 reference

Conformational and Coordination Equilibria on DOTA Complexes of Lanthanide Metal Ions in Aqueous Solution Studied by (1)H-NMR Spectroscopy

21 January 2018

1 reference

Solution dynamics and stability of lanthanide(III) (S)-2-(p-nitrobenzyl)DOTA complexes.

21 January 2018

1 reference

An 86Y-labeled mirror-image oligonucleotide: influence of Y-DOTA isomers on the biodistribution in rats

21 January 2018

1 reference

Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

21 January 2018

1 reference

True radiotracers: Cu-64 targeting vectors based upon bombesin peptide.

21 January 2018

1 reference

Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates

21 January 2018

1 reference

Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and (64)Cu radiolabelling.

21 January 2018

1 reference

(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity

21 January 2018

1 reference

Evaluation of Copper-64 Labeled AmBaSar Conjugated Cyclic RGD Peptide for Improved MicroPET Imaging of Integrin αvβ3 Expression

21 January 2018

1 reference

Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes

21 January 2018

1 reference

Versatile new bis(thiosemicarbazone) bifunctional chelators: synthesis, conjugation to bombesin(7-14)-NH(2), and copper-64 radiolabeling

21 January 2018

1 reference

The role of coordination chemistry in the development of target-specific radiopharmaceuticals

21 January 2018

1 reference

Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era.

21 January 2018

1 reference

Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours

21 January 2018

1 reference

Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection

21 January 2018

1 reference

Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer

21 January 2018

1 reference

RP463: a stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging

21 January 2018

1 reference

Phosphine-containing HYNIC derivatives as potential bifunctional chelators for (99m)Tc-labeling of small biomolecules

21 January 2018

1 reference

Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules

21 January 2018

1 reference

A Novel Organometallic Aqua Complex of Technetium for the Labeling of Biomolecules: Synthesis of [99mTc(OH2)3(CO)3] from [99mTcO4]-in Aqueous Solution and Its Reaction with a Bifunctional Ligand

21 January 2018

1 reference

Synthesis and properties of boranocarbonate: a convenient in situ CO source for the aqueous preparation of [(99m)Tc(OH(2))3(CO)3] .

21 January 2018

1 reference

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

Role of integrins in cell invasion and migration

21 January 2018

1 reference

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism

21 January 2018

1 reference

Integrins: roles in cancer development and as treatment targets

21 January 2018

1 reference

Role of integrins in cancer: survey of expression patterns

21 January 2018

1 reference

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

21 January 2018

1 reference

Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?

21 January 2018

1 reference

New perspectives in cell adhesion: RGD and integrins

21 January 2018

1 reference

Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.

21 January 2018

1 reference

Ligands for mapping alphavbeta3-integrin expression in vivo.

21 January 2018

1 reference

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression

21 January 2018

1 reference

Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency

21 January 2018

1 reference

Molecular imaging of angiogenesis with SPECT.

21 January 2018

1 reference

Positron emission tomography tracers for imaging angiogenesis

21 January 2018

1 reference

The structures of integrins and integrin-ligand complexes: implications for drug design and signal transduction

21 January 2018

1 reference

(90)Y and (177)Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy

21 January 2018

1 reference

Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting

21 January 2018

1 reference

99mTc-labeling of a hydrazinonicotinamide-conjugated vitronectin receptor antagonist useful for imaging tumors

21 January 2018

1 reference

Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide

21 January 2018

1 reference

Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer

21 January 2018

1 reference

Linker effects on biological properties of 111In-labeled DTPA conjugates of a cyclic RGDfK dimer

21 January 2018

1 reference

99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand

21 January 2018

1 reference

(64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression

21 January 2018

1 reference

Template assembled cyclopeptides as multimeric system for integrin targeting and endocytosis

21 January 2018

1 reference

Multimerization of cRGD Peptides by Click Chemistry: Synthetic Strategies, Chemical Limitations, and Influence on Biological Properties

21 January 2018

1 reference

Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide

21 January 2018

1 reference

99mTc-NC100692--a tracer for imaging vitronectin receptors associated with angiogenesis: a preclinical investigation

21 January 2018

1 reference

An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the alpha v beta 3-selective angiogenesis imaging agent 99mTc-NC100692.

21 January 2018

1 reference

Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer

21 January 2018

1 reference

Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers

21 January 2018

1 reference

Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers

21 January 2018

1 reference

Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers

21 January 2018

1 reference

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging

21 January 2018

1 reference

Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers

21 January 2018

1 reference

Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent

21 January 2018

1 reference

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

21 January 2018

1 reference

New peptide in the vertebrate CNS reacting with antigastrin antibodies

21 January 2018

1 reference

Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth

21 January 2018

1 reference

Targeting CCK receptors in human cancers

21 January 2018

1 reference

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

21 January 2018

1 reference

Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin

21 January 2018

1 reference

Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives

21 January 2018

1 reference

Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies

21 January 2018

1 reference

Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.

21 January 2018

1 reference

Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.

21 January 2018

1 reference

Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy

21 January 2018

1 reference

Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluation

21 January 2018

1 reference

Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide

21 January 2018

1 reference

Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides

21 January 2018

1 reference

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma

21 January 2018

1 reference

Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

21 January 2018

1 reference

99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo

21 January 2018

1 reference

Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: from molecular modeling to in vivo evaluation.

21 January 2018

1 reference

Synthesis, characterization and in vitro evaluation of new oxorhenium- and oxotechnetium-CCK4 derivatives as molecular imaging agents for CCK2-receptor targeting.

21 January 2018

1 reference

Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors

21 January 2018

1 reference

In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with 99mTc-tricarbonyl

21 January 2018

1 reference

Vasoactive intestinal polypeptide and related peptides. Isolation and chemistry

21 January 2018

1 reference

99mTc labeled VIP analog: evaluation for imaging colorectal cancer

21 January 2018

1 reference

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation

21 January 2018

1 reference

PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer

21 January 2018

1 reference

Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products

21 January 2018

1 reference

99mTc(CO)3-VIP analogues: preparation and evaluation as tumor imaging agent.

21 January 2018

1 reference

High expression of peptide receptors as a novel target in gastrointestinal stromal tumours

21 January 2018

1 reference

International Union of Pharmacology. XXXV. The glucagon receptor family

21 January 2018

1 reference

Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results

21 January 2018

1 reference

A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.

21 January 2018

1 reference

[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma.

21 January 2018

1 reference

Glucagon-like peptide 1-receptor scans to localize occult insulinomas.

21 January 2018

1 reference

Glucagon-like peptide-1 receptor imaging for localization of insulinomas

21 January 2018

1 reference

Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT.

21 January 2018

1 reference

68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

21 January 2018

1 reference

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

21 January 2018

1 reference

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

21 January 2018

1 reference

Quantitation of CXCR4 expression in myocardial infarction using 99mTc-labeled SDF-1alpha

21 January 2018

1 reference

Neuropeptide Y: complete amino acid sequence of the brain peptide

21 January 2018

1 reference

Neuropeptide Y: the universal soldier

21 January 2018

1 reference

NPY receptors in human cancer: a review of current knowledge

21 January 2018

1 reference

Neuropeptide Y receptor expression in human primary ovarian neoplasms

21 January 2018

1 reference

High expression of neuropeptide y receptors in tumors of the human adrenal gland and extra-adrenal paraganglia

21 January 2018

1 reference

Neuropeptide Y receptors in primary human brain tumors: overexpression in high-grade tumors

21 January 2018

1 reference

99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents

21 January 2018

1 reference

Radiometal targeted tumor diagnosis and therapy with peptide hormones

21 January 2018

1 reference

Novel chemically modified analogues of neuropeptide Y for tumor targeting

21 January 2018

1 reference

Breast-cancer diagnosis by neuropeptide Y analogues: from synthesis to clinical application

21 January 2018

1 reference

First selective agonist of the neuropeptide Y1-receptor with reduced size

21 January 2018

1 reference

[Lys(DOTA)4]BVD15, a novel and potent neuropeptide Y analog designed for Y1 receptor-targeted breast tumor imaging

21 January 2018

1 reference

Melanocortin ligands: 30 years of structure-activity relationship (SAR) studies

21 January 2018

1 reference

Melanocortin-1 receptor-targeting with radiolabeled cyclic α-melanocyte-stimulating hormone analogs for melanoma imaging

21 January 2018

1 reference

Peptide-targeted radionuclide therapy for melanoma

21 January 2018

1 reference

Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3] : effect of cyclization on tumor-seeking properties.

21 January 2018

1 reference

A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting

21 January 2018

1 reference

64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression

21 January 2018

1 reference

Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution

21 January 2018

1 reference

Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity

21 January 2018

1 reference

Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination

21 January 2018

1 reference

Alpha-melanocyte-stimulating hormone peptide analogs labeled with technetium-99m and indium-111 for malignant melanoma targeting

21 January 2018

1 reference

Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues

21 January 2018

1 reference

In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy

21 January 2018

1 reference

Evaluation of the Human Melanoma Targeting Properties of Radiolabeled α-Melanocyte Stimulating Hormone Peptide Analogues

21 January 2018

1 reference

Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.

21 January 2018

1 reference

Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.

21 January 2018

1 reference

Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors

21 January 2018

1 reference

Melanoma therapy via peptide-targeted {alpha}-radiation

21 January 2018

1 reference

Evaluation of a novel Arg-Gly-Asp-conjugated α-melanocyte stimulating hormone hybrid peptide for potential melanoma therapy.

21 January 2018

1 reference

111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging

21 January 2018

1 reference

Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging

21 January 2018

1 reference

Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide

21 January 2018

1 reference

Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake

21 January 2018

1 reference

Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities

21 January 2018

1 reference

Neurotensin receptors: a new marker for human ductal pancreatic adenocarcinoma

21 January 2018

1 reference

Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression

21 January 2018

1 reference

In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors

21 January 2018

1 reference

Stabilization of neurotensin analogues: effect on peptide catabolism, biodistribution and tumor binding

21 January 2018

1 reference

A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours

21 January 2018

1 reference

Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties

21 January 2018

1 reference

[99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.

21 January 2018

1 reference

Double-stabilized neurotensin analogues as potential radiopharmaceuticals for NTR-positive tumors.

21 January 2018

1 reference

Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer

21 January 2018

1 reference

Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.

21 January 2018

1 reference

Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes

21 January 2018

1 reference

Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study

21 January 2018

1 reference

Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells

21 January 2018

1 reference

A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent

21 January 2018

1 reference

[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

21 January 2018

1 reference

A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation

21 January 2018

1 reference

Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3] moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.

21 January 2018

1 reference

Chemical and biological characterization of new Re(CO)3/[99mTc](CO)3 bombesin analogues

21 January 2018

1 reference

99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor

21 January 2018

1 reference

99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer

21 January 2018

1 reference

Spacer site modifications for the improvement of the in vitro and in vivo binding properties of (99m)Tc-N(3)S-X-bombesin[2-14] derivatives

21 January 2018

1 reference

MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue.

21 January 2018

1 reference

In vitro and in vivo evaluation of a 64Cu-labeled polyethylene glycol-bombesin conjugate

21 January 2018

1 reference

Comparative in vitro and in vivo evaluation of two 64Cu-labeled bombesin analogs in a mouse model of human prostate adenocarcinoma.

21 January 2018

1 reference

In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties

21 January 2018

1 reference

Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).

21 January 2018

1 reference

In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems

21 January 2018

1 reference

[64Cu-NOTA-8-Aoc-BBN(7-14)NH2] targeting vector for positron-emission tomography imaging of gastrin-releasing peptide receptor-expressing tissues

21 January 2018

1 reference

In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors

21 January 2018

1 reference

Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse model

21 January 2018

1 reference

68Ga-labeled bombesin studies in patients with gastrointestinal stromal tumors: comparison with 18F-FDG.

21 January 2018

1 reference

DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours

21 January 2018

1 reference

Novel 111In-labelled bombesin analogues for molecular imaging of prostate tumours

21 January 2018

1 reference

Receptor-binding, biodistribution, dosimetry, and micro-SPECT/CT imaging of 111In-[DTPA(1), Lys(3), Tyr(4)]-bombesin analog in human prostate tumor-bearing mice

21 January 2018

1 reference

Synthesis and evaluation of bombesin derivatives on the basis of pan-bombesin peptides labeled with indium-111, lutetium-177, and yttrium-90 for targeting bombesin receptor-expressing tumors

21 January 2018

1 reference

Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice

21 January 2018

1 reference

Selective in vitro targeting of GRP and NMB receptors in human tumours with the new bombesin tracer 177Lu-AMBA.

21 January 2018

1 reference

177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression

21 January 2018

1 reference

In vitro binding evaluation of 177Lu-AMBA, a novel 177Lu-labeled GRP-R agonist for systemic radiotherapy in human tissues

21 January 2018

1 reference

Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours

21 January 2018

1 reference

99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours

21 January 2018

1 reference

Cell-specific and nuclear targeting with [M(CO)(3)]( ) (M=(99m)Tc, Re)-based complexes conjugated to acridine orange and bombesin

21 January 2018

1 reference

1,4,7-Triazacyclononane-N,N',N''-triacetate (TCTA), a new hexadentate ligand for divalent and trivalent metal ions. Crystal structures of [CrIII(TCTA)], [FeIII(TCTA)], and Na[CuII(TCTA)].bul.2NaBr.bul.8H2O

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1039/C0DT01599G

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21350775 AND SRC:MED&resulttype=core&format=json

23 January 2020

1 reference